Drugs Made In America Acquisition Corp. (DMAAR) at a glance

Drugs Made In America Acquisition Corp. (DMAAR) is a micro-cap company. It trades at $0.1, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (34/100).

Price

$0.10

Market cap

$2.0M

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$0.04 to $0.24